Technology


 |
 |
Introduction
APS technology exploits the natural
binding, therapeutic and delivery properties of Human Serum Albumin
(HSA) to provide a vehicle for enhancing performance of a wide range
of drugs and therapeutic agents. The products will all be
•
cost effective
•
easy to store and administer and
•
with long shelf lives.
|
|




|
|
|